Barclays Private Equity buys UETIKON

Following the acquisition, the investor is holding 90% and the management will take over the remaining stake. UETIKON will focus on the manufacturing of active pharmaceutical ingredients and fine chemicals and target the pharmaceuticals, cosmetics and nutrition industries.

In August, Barclays Private Equity took over IN tIME Express Logistik in a secondary buyout from ECM Equity Capital Management.

Company
CU Chemie UETIKON is a spin-off from the Swiss group CPH Chemie + Paper Holding. The company manufactures fine chemicals and active pharmaceutical ingredients. Based in Lahr, the firm develops custom synthesis of multilevel intermediaries and active pharmaceutical ingredients.

UETIKON had a turnover of around €17m in the first half of 2011 and expects a revenue growth of over 30% for the full financial year or 2011, compared to 2010. Founded in 1970, the chemical specialist employs more than 110 people.

People
Philippe Stüdi and Marc Erni led the investment for Barclays Private Equity.

Advisers
Equity - PricewaterCoopers (Financial due diligence, tax); Rothgordt & Cie (Commercial due diligence); Lenz & Staehelin (Legal); de Angelis Rechtsanwälte (Legal); Ecosens (Environmental due diligence).

 

 

 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Buyouts
• Industrials
• Germany
• Barclays Private Equity